Owner AstraZeneca AB (Publ)

Inventors Simpson, Iain; Higginbottom, Michael; Chapman, Emma; Horgan, Anne VietAnh (nee Nguyen)

Agent Davies Collison Cave

Pub. Number AU-A-2009254557

PCT Pub. Number WO2009/147221

Priority 0801321-1 04.06.08 SE; 61/082,336 21.07.08 US

Filing date 4 June 2009

Wipo publication date 10 December 2009

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 295/088 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms